Cargando…
Successful treatment of primary bone marrow Hodgkin lymphoma with brentuximab vedotin: a case report and review of the literature
BACKGROUND: Hodgkin lymphoma usually presents with sequential enlargement of peripheral lymph nodes, and bone marrow invasion rarely occurs (approximately 3–5%). However, several cases have been reported as “primary” bone marrow Hodgkin lymphoma, especially among patients with human immunodeficiency...
Autores principales: | Nagaharu, Keiki, Masuya, Masahiro, Kageyama, Yuki, Yamaguchi, Takanori, Ito, Ryugo, Kawakami, Keiki, Ito, Masafumi, Katayama, Naoyuki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5975584/ https://www.ncbi.nlm.nih.gov/pubmed/29843820 http://dx.doi.org/10.1186/s13256-018-1693-0 |
Ejemplares similares
-
Successful Management of Immune Thrombocytopenia Presenting with Lethal Alveolar Hemorrhage
por: Nagaharu, Keiki, et al.
Publicado: (2019) -
A Rare Case of Immunotactoid Glomerulopathy Associated with Hodgkin Lymphoma
por: Nagaharu, Keiki, et al.
Publicado: (2021) -
Brentuximab vedotin for relapsed or refractory Hodgkin’s lymphoma
por: Chen, Runzhe, et al.
Publicado: (2015) -
Brentuximab Vedotin Treatment for Primary Refractory Hodgkin Lymphoma
por: Wu, Hung-Bo, et al.
Publicado: (2013) -
Desensitization of Brentuximab Vedotin in a Patient with Hodgkin Lymphoma
por: Khalid, Sidra, et al.
Publicado: (2018)